Avanos Medical, Inc. (AVNS)
NYSE: AVNS · Real-Time Price · USD
13.10
+0.45 (3.56%)
At close: May 12, 2025, 4:00 PM
13.10
0.00 (0.00%)
After-hours: May 12, 2025, 7:00 PM EDT
Avanos Medical Revenue
Avanos Medical had revenue of $167.50M in the quarter ending March 31, 2025, with 0.84% growth. This brings the company's revenue in the last twelve months to $689.20M, up 1.34% year-over-year. In the year 2024, Avanos Medical had annual revenue of $687.80M with 2.15% growth.
Revenue (ttm)
$689.20M
Revenue Growth
+1.34%
P/S Ratio
0.87
Revenue / Employee
$309,475
Employees
2,227
Market Cap
605.80M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 687.80M | 14.50M | 2.15% |
Dec 31, 2023 | 673.30M | -10.80M | -1.58% |
Dec 31, 2022 | 684.10M | 97.10M | 16.54% |
Dec 31, 2021 | 587.00M | -127.80M | -17.88% |
Dec 31, 2020 | 714.80M | 17.20M | 2.47% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
AVNS News
- 6 days ago - Avanos Medical, Inc. (AVNS) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 6 days ago - Avanos Medical, Inc. Announces First Quarter 2025 Results - PRNewsWire
- 14 days ago - Avanos Medical, Inc. to Webcast Conference Call Discussing First Quarter 2025 Financial Results - PRNewsWire
- 5 weeks ago - Avanos Expands Direct Operations for MIC-KEY* Enteral Feeding Products in the UK starting July 2025 - PRNewsWire
- 2 months ago - Avanos Medical Announces Appointment of David Pacitti as Chief Executive Officer - PRNewsWire
- 2 months ago - Avanos Medical Inc. (AVNS) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Avanos Medical, Inc. Announces Fourth Quarter and Full-Year 2024 Results - PRNewsWire
- 2 months ago - Avanos Medical, Inc. to Webcast Conference Call Discussing Fourth Quarter and Full Year 2024 Financial Results - PRNewsWire